Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions
Clinical trial NCT03702894 · COMPLETED
Trial details
- NCT number
- NCT03702894
- Sponsor
- Pharmtechnology LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2018-10-08
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.